文献速递腹部介入US

低强度聚焦超声在胰腺癌中引发免疫反应

Low-Intensity Focused Ultrasound Produces Immune Response in Pancreatic Cancer.
PubMed 文献 · Ultrasound Med Biol · 2022-08-24

该研究在C57BL/6小鼠皮下胰腺肿瘤模型中,采用低强度聚焦超声联合微泡(LoFU+MBs)治疗,于治疗后2天和15天通过流式细胞术与组织学评估免疫细胞格局及损伤相关分子模式(DAMPs)的表达与定位。结果显示治疗后2天引流淋巴结中活化抗原呈递细胞(如巨噬细胞)显著增加,CD8+和CD4+ T细胞扩增,HMGB1胞质指数升高,提示局部损伤和DAMP信号转位;治疗15天后肿瘤生长显著减慢,但多数免疫效应消退,且较大肿瘤中2天时的效应减弱。研究认为聚焦超声可诱导肿瘤损伤及巨噬细胞和T细胞变化,为聚焦超声与免疫治疗联合的合理设计提供了工作平台。

要点

  • LoFU+MBs治疗后2天引流淋巴结活化抗原呈递细胞及CD8+/CD4+ T细胞显著增加。
  • 治疗2天时HMGB1胞质指数升高,提示DAMP信号转位。
  • 单次治疗后15天肿瘤生长显著减慢,但多数免疫效应消退。

关键影像表现/征象

  • 治疗后2天引流淋巴结中活化抗原呈递细胞(如巨噬细胞)显著增加。
  • 治疗后2天引流淋巴结中CD8+ T细胞和CD4+ T细胞扩增。
  • LoFU+MB治疗引起局部损伤,表现为2天时HMGB1胞质指数增加,提示DAMP信号转位。

临床应用与阅片要点

  • 聚焦超声联合微泡治疗后可早期(2天)评估引流淋巴结免疫细胞变化及肿瘤内HMGB1胞质转位。
  • 单次治疗后免疫效应在15天时多已消退,提示需多次治疗或联合免疫治疗。
  • 较大肿瘤中2天时的免疫效应减弱,即使增加治疗次数,需注意肿瘤大小对疗效的影响。

局限性

  • 研究为小鼠皮下肿瘤模型,并非原位胰腺癌模型。
  • 单次治疗后多数免疫效应在15天消退,长期免疫记忆未评估。
  • 较大肿瘤中早期效应减弱,提示模型存在肿瘤负荷依赖性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Pancreatic adenocarcinoma is an aggressive malignancy with limited therapeutic treatments available and a 5-y survival less than 10%. Pancreatic cancers have been found to be immunogenically "cold" with a largely immunosuppressive tumor microenvironment. There is emerging evidence that focused ultrasound can induce changes in the tumor microenvironment and have a constructive impact on the effect of immunotherapy. However, the immune cells and timing involved in these effects remain unclear, which is essential to determining how to combine immunotherapy with ultrasound for treatment of pancreatic adenocarcinoma. We used low-intensity focused ultrasound and microbubbles (LoFU + MBs), which can mechanically disrupt cellular membranes and vascular endothelia, to treat subcutaneous pancreatic tumors in C57BL/6 mice. To evaluate the immune cell landscape and expression and/or localization of damage-associated molecular patterns (DAMPs) as a response to ultrasound, we performed flow cytometry and histology on tumors and draining lymph nodes 2 and 15 d post-treatment. We repeated this study on larger tumors and with multiple treatments to determine whether similar or greater effects could be achieved. Two days after treatment, draining lymph nodes exhibited a significant increase in activated antigen presenting cells, such as macrophages, as well as expansion of CD8+ T cells and CD4+ T cells. LoFU + MB treatment caused localized damage and facilitated the translocation of DAMP signals, as reflected by an increase in the cytoplasmic index for high-mobility-group box 1 (HMGB1) at 2 d. Tumors treated with LoFU + MBs exhibited a significant decrease in growth 15 d after treatment, indicating a tumor response that has the potential for additive effects. Our studies indicate that focused ultrasound treatments can cause tumoral damage and changes in macrophages and T cells 2 d post-treatment. The majority of these effects subsided after 15 d with only a single treatment, illustrating the need for additional treatment types and/or combination with immunotherapy. However, when larger tumors were treated, the effects seen at 2 d were diminished, even with an additional treatment. These results provide a working platform for further rational design of focused ultrasound and immunotherapy combinations in poorly immunogenic cancers.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Joiner, Kren, Durham, et al. Low-Intensity Focused Ultrasound Produces Immune Response in Pancreatic Cancer. Ultrasound Med Biol. 2022. PMID: 36028460. doi:10.1016/j.ultrasmedbio.2022.06.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。